Mind Meld Team Grant Program supports multidisciplinary teams combining laboratory and clinical research to advance patient-centered food allergy treatments with near-term potential to improve care.
FARE made formatting-only updates to the Mind Meld Team Grant guidelines, adjusting headings, emphasis, punctuation, spacing, and page numbering.
Funder: Food Allergy Research & Education
Due Dates: September 2, 2026 (LOI) | December 18, 2026 (Invited full application)
Funding Amounts: Up to $10 million total, awarded to one or more teams for up to four years, including indirect costs
Summary: Supports multidisciplinary, milestone-driven laboratory and clinical research to accelerate patient-centered food allergy treatments.
Key Information: The lead institution must be a current member of the third cohort of the FARE Clinical Network.
Food Allergy Research & Education (FARE) runs this program to accelerate breakthrough discoveries through convergence science and collaborative translational research. Shaped by the Mind Meld Innovation Summit, it supports teams combining laboratory and clinical research to advance mechanistically grounded interventions with near-term potential to improve food allergy care.
Research opportunities include biomarkers, targeted and sequential immunotherapies, allergic effector cell modulation, host–microbiota interactions, engineered antibodies, cellular therapies, and artificial intelligence-enabled discovery. These examples are not exhaustive. The program emphasizes multidisciplinary collaboration, patient and caregiver involvement, and measurable progress toward patient-centered outcomes. Projects must include human studies beginning by the midpoint of the award and completing within the grant period.